For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Exocobio Inc.

USPTO Granted Patents = 13

EPO Patents = 5

Trademarks = 10

Forward Citations = 9

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Byong Seung Cho (13 out of 13 patents)

Yong Weon Yi (9 out of 9 patents)

Kwang Il Kim (2 out of 2 patents)

4. So Young Lee (1 out of 173 patents)

5. Ji Hyun Seo (1 out of 19 patents)

6. Kwang Ii Kim (1 out of 1 patent)

7. Sung Hun Youn (1 out of 2 patents)

8. Mu Hyun Jin (1 out of 5 patents)

9. Yu Jin Won (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12751988 - Composition comprising-derived exosomes as active ingredient (2026-10-06),

2. 12636337 - Composition for anti-inflammation, wound healing or wound healing promotion, comprising rose stem cell-derived exosomes as active ingredient (2026-05-26),

3. 12605331 - Composition comprising iris-derived exosome as active ingredient (2026-04-21),

4. 12491151 - Cosmetic composition comprising black yeast-derived exosomes (2025-12-09),

5. 11850297 - Composition comprising sapogenin and exosome as effective ingredient (2023-12-26),

6. 11730695 - Composition for alleviating facial redness, comprising stem cell-derived exosomes as active ingredient (2023-08-22),

7. 11690797 - Cosmetic composition comprising rose stem cell-derived exosome as effective ingredient (2023-07-04),

8. 11612621 - Use of composition comprising exosome derived from adipose-derived stem cell as effective ingredient in ameliorating dermatitis (2023-03-28),

9. 11534392 - Cosmetic composition comprising exosomes derived from galactomyces as active ingredient (2022-12-27),

10. 11529370 - Use of composition comprising stem cell-derived exosome as effective ingredient in strengthening skin barrier and improving skin barrier function (2022-12-20),

11. 11529306 - Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient (2022-12-20),

12. 11446333 - Use of composition comprising stem cell-derived exosome as effective ingredient for suppression or alleviation of pruritus (2022-09-20),

13. 11337419 - Method for lyophilizing exosome (2022-05-24),

Company Overview

Exocobio Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of innovative solutions for healthcare and environmental applications. The organization focuses on harnessing advanced biotechnological methods to create products that enhance human health and address ecological challenges. With a commitment to research and development, Exocobio aims to contribute to the advancement of sustainable practices and improve quality of life through its cutting-edge technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#319 in Seoul

#878 in South Korea

#45,081 in the World

Seoul, South Korea

Exocobio Inc.

Forward Citations = 9

9 inventors:

Byong Seung Cho (13 out of 13 patents)

Yong Weon Yi (9 out of 9 patents)

Kwang Il Kim (2 out of 2 patents)

4. So Young Lee (1 out of 173 patents)

5. Ji Hyun Seo (1 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Exocobio Inc.. Retrieved from https://idiyas.com/company/exocobio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…